Clinical Trial Update: Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of the PfSPZ Vaccine in pregnant women in Mali (MalVIP1) is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 1 | Status: SUSPENDED